MURFRESSBORO, Tenn. (PRWEB)
September 15, 2022
TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, today announced they received Global Health & Pharma’s 2022 award for Most Patient-Centric Chronic Care Medication Management Company – USA.
“GHP is proud to present TwelveStone Health Partners with the prestigious accolade of 2022’s Most Patient-Centric Chronic Care Medication Management Company based on their incredible patient feedback for pharmacy services delivered through their infusion centers, packaged medications and in-home infusion and enteral services throughout the Southeastern United States. TwelveStone has not only impressed us with its clinical innovation but has also left us in awe with its fine customer service”, shared Sofi Bajor, editor, Global Health & Pharma.
The Global Health and Pharma Awards recognize businesses for their excellent work in the healthcare and pharmaceutical sphere and seek out businesses making a positive mark in the world of health.
“We are so appreciative to the editors of Global Health & Pharma for recognizing the impact TwelveStone Health Partners is making on those struggling with complex, chronic conditions, ” says Shane Reeves, chief executive officer, TwelveStone Health Partners. “As Americans age, offering differentiated, patient-centric medication services will become even more critical to ensuring compliance and ensuring positive outcomes.”
Today’s GHP award adds to a growing list of accolades for TwelveStone, who was also recently named to the INC 5,000 list of companies for the third year in a row.
About TwelveStone Partners
TwelveStone Health Partners incorporates the objective of glorifying God into its mission by delivering a higher level of service to partners and patients. As an organization, TwelveStone supports the transition from acute to post-acute care environments and the transition from sickness to health. This is the third evolution in the company’s history, beginning in 1980 when Richard Reeves and Ronald Powell created a single retail pharmacy location then called Reeves Powell Saveway Drug Store. In 1994 Shane Reeves and Rick Sain launched Reeves-Sain, and over 20 years grew the organization to include seven companies. In 2015 Reeves Sain Drug Store, Inc., a retail pharmacy, and its specialty pharmacy, EntrustRx were sold to Fred’s, Inc. In 2016 Shane Reeves launched TwelveStone Health Partners, intending to continue pursuing the highest professional, business, and community goals set forth by its founders. For more information, visit http://www.12stonehealth.com.
Forward Looking Statements
This press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on TwelveStone Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Additional information concerning TwelveStone Health and its business, including a discussion of factors that could materially affect the company operating results, is contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on March 31, 2022, under the heading “Risk Factors,” as well as the Company’s subsequent filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and TwelveStone Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.
Share article on social media or email: